JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 28, 2007; DOI: 10.1124/jpet.107.120857


0022-3565/07/3213-1193-1207$20.00
JPET 321:1193-1207, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.120857v1
321/3/1193    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griffin, M. T.
Right arrow Articles by Ehlert, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffin, M. T.
Right arrow Articles by Ehlert, F. J.

CELLULAR AND MOLECULAR

Estimation of Agonist Activity at G Protein-Coupled Receptors: Analysis of M2 Muscarinic Receptor Signaling through Gi/o,Gs, and G15

Michael T. Griffin, Katherine W. Figueroa, Sarah Liller, and Frederick J. Ehlert

Department of Physical Sciences, Chapman University, Orange, California (M.T.G., S.L.); and Department of Pharmacology, School of Medicine, University of California, Irvine, Irvine, California (K.W.F., F.J.E.)

We developed novel methods for analyzing the concentration-response curve of an agonist to estimate the product of observed affinity and intrinsic efficacy, expressed relative to that of a standard agonist. This parameter, termed intrinsic relative activity (RAi), is most applicable for the analysis of responses at G protein-coupled receptors. RAi is equivalent to the potency ratios that agonists would exhibit in a hypothetical, highly sensitive assay in which all agonists behave as full agonists, even those with little intrinsic efficacy. We investigated muscarinic responses at the M2 receptor, including stimulation of phosphoinositide hydrolysis through G{alpha}15 in HEK 293T cells, inhibition of cAMP accumulation through Gi in Chinese hamster ovary (CHO) cells, and stimulation of cAMP accumulation through Gs in CHO cells treated with pertussis toxin. The RAi values of carbachol, oxotremorine-M, and the enantiomers of aceclidine were approximately the same in the three assay systems. In contrast, the activity of 4-[[N-[3-chlorophenyl]carbamoy]oxy-2-butynyl]trimethylammonium chloride (McN-A-343) was ~10-fold greater at M2 receptors coupled to G{alpha}15 in HEK 293T cells compared with M2 receptors coupled to Gi in the same cells or in CHO cells. Our results show that the RAi estimate is a useful measure for quantifying agonist activity across different assay systems and for detecting agonist directed signaling.


Received January 31, 2007; accepted March 26, 2007.

Address correspondence to: Dr. Frederick J. Ehlert, Department of Pharmacology, University of California, Irvine, Irvine, CA 92697-4625. E-mail: fjehlert{at}uci.edu




This article has been cited by other articles:


Home page
Mol. Interv.Home page
C. Valant, P. M. Sexton, and A. Christopoulos
Orthosteric/Allosteric Bitopic Ligands: Going Hybrid at GPCRs
Mol. Interv., June 1, 2009; 9(3): 125 - 135.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. A. Tran, A. Chang, M. Matsui, and F. J. Ehlert
Estimation of Relative Microscopic Affinity Constants of Agonists for the Active State of the Receptor in Functional Studies on M2 and M3 Muscarinic Receptors
Mol. Pharmacol., February 1, 2009; 75(2): 381 - 396.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. W. Figueroa, M. T. Griffin, and F. J. Ehlert
Selectivity of Agonists for the Active State of M1 to M4 Muscarinic Receptor Subtypes
J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 331 - 342.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Valant, K. J. Gregory, N. E. Hall, P. J. Scammells, M. J. Lew, P. M. Sexton, and A. Christopoulos
A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity: MUSCARINIC PARTIAL AGONIST McN-A-343 AS A BITOPIC ORTHOSTERIC/ALLOSTERIC LIGAND
J. Biol. Chem., October 24, 2008; 283(43): 29312 - 29321.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.